German venture capital firm MIG AG, which was among the first backers of COVID-19 vaccine developer BioNTech, has paid €600 million (US$719 million) to its investors, cashing out parts of an initial investment of €13.5 million
Early backers of COVID-19 vaccine maker BioNTech in US$719 million payday
